Understanding Fecal Microbiota Transplant: A Promising Treatment for CDI

Fecal microbiota transplantation (FMT) is an innovative procedure transferring healthy fecal bacteria to treat Clostridioides difficile infection. With an effectiveness of 85-90%, FMT is also being explored for conditions like ulcerative colitis, IBS, and neurological disorders, marking a significant advancement in microbiome-based therapies.

5/8/20241 min read

green plant in white ceramic pot
green plant in white ceramic pot

Fecal Microbiota Transplant

Transforming lives through microbiota transplantation solutions.

Care

Science

info@fmt.life

+1234567890

© 2024. All rights reserved.

Helpful Links | Get Involved | Let’s Connect
  • Our Mission and Story | Join Us | Contact Us: info@fmt-life.org
  • Latest Features | Donate | Phone: (617) 575-2201
  • Global Microbiome Conservancy (GMbC) | Careers |
  • FMT for Patients
  • FMT for Clinicians
The investigational fecal microbiota transplantation (FMT) treatments discussed on this website and associated materials have not been approved or licensed by the U.S. Food and Drug Administration or any other regulatory authority, and are not commercially available. FMT-Life acts solely as the distributor of investigational FMT preparations manufactured by the University of Minnesota under an FDA-reviewed Investigational New Drug (IND) application.
Before placing an order for any investigational FMT from FMT-Life/UMN, a licensed physician must complete a registration form, agree to comply with all applicable regulatory requirements designed to protect patients, and be added as an investigator to the research IND that authorizes expanded access to the investigational biologic for eligible patients.